Literature DB >> 21865475

Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.

Ornella Valenti1, Pierangelo Cifelli, Kathryn M Gill, Anthony A Grace.   

Abstract

Repeated administration of antipsychotic drugs to normal rats has been shown to induce a state of dopamine neuron inactivation known as depolarization block, which correlates with the ability of the drugs to exhibit antipsychotic efficacy and extrapyramidal side effects in schizophrenia patients. Nonetheless, in normal rats depolarization block requires weeks of antipsychotic drug administration, whereas schizophrenia patients exhibit initial effects soon after initiating antipsychotic drug treatment. We now report that, in a developmental disruption rat model of schizophrenia [methyl-azoxymethanol acetate (20 mg/kg, i.p.) injected into G17 pregnant female rats, with offspring tested as adults], the extant hyperdopaminergic state combines with the excitatory actions of a first- (haloperidol; 0.6 mg/kg, i.p.) and a second- (sertindole; 2.5 mg/kg, i.p.) generation antipsychotic drug to rapidly induce depolarization block in ventral tegmental area dopamine neurons. Acute injection of either antipsychotic drug induced an immediate reduction in the number of spontaneously active dopamine neurons (cells per electrode track; termed population activity). Repeated administration of either antipsychotic drug for 1, 3, 7, 15, and 21 d continued to reduce dopamine neuron population activity. Both acute and repeated effects on population activity were reversed by acute apomorphine injections, which is consistent with the reversal of dopamine neuron depolarization block. Although this action may account for the effects of D2 antagonist drugs on alleviating psychosis and the lack of development of tolerance in humans, the drugs appear to do so by inducing an offsetting deficit rather than attacking the primary pathology present in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865475      PMCID: PMC3167216          DOI: 10.1523/JNEUROSCI.2808-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

Review 1.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Authors:  S Kapur; P Seeman
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 2.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

Authors:  A A Grace
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 3.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

Authors:  R J Baldessarini; B M Cohen; M H Teicher
Journal:  Arch Gen Psychiatry       Date:  1988-01

Review 4.  Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

Authors:  S Kapur; G Remington
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

Review 5.  Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.

Authors:  Anthony A Grace
Journal:  Neurotox Res       Date:  2010-02-09       Impact factor: 3.911

6.  Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.

Authors:  S Nyberg; A L Nordström; C Halldin; L Farde
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

7.  Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo.

Authors:  A R West; A A Grace
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

8.  Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.

Authors:  T Skarsfeldt
Journal:  Synapse       Date:  1992-01       Impact factor: 2.562

9.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

10.  Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

View more
  46 in total

1.  Gestational methylazoxymethanol acetate administration alters proteomic and metabolomic markers of hippocampal glutamatergic transmission.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 2.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

Review 3.  Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations.

Authors:  C C Abbott; A Jaramillo; C E Wilcox; D A Hamilton
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2020-07-14       Impact factor: 7.853

5.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

Review 6.  Implications of cellular models of dopamine neurons for schizophrenia.

Authors:  Na Yu; Kristal R Tucker; Edwin S Levitan; Paul D Shepard; Carmen C Canavier
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

7.  An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.

Authors:  Li Chen; Stephanie M Perez; Daniel J Lodge
Journal:  Dev Neurobiol       Date:  2014-03-03       Impact factor: 3.964

Review 8.  The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context.

Authors:  J J Walsh; M H Han
Journal:  Neuroscience       Date:  2014-06-12       Impact factor: 3.590

9.  Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Authors:  Kathryn M Gill; James M Cook; Michael M Poe; Anthony A Grace
Journal:  Schizophr Bull       Date:  2014-01-24       Impact factor: 9.306

10.  Pacemaker rate and depolarization block in nigral dopamine neurons: a somatic sodium channel balancing act.

Authors:  Kristal R Tucker; Marco A Huertas; John P Horn; Carmen C Canavier; Edwin S Levitan
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.